• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Hikal Ltd.
    07 Aug 2025
    255.00
    -1.39%
    Smallcap pharma stock hits 52-week low, slips 8% on Q1 loss. Do you own?
    Business Standard
    Shares of Hikal hit a 52-week low of 281.90, falling 8 per cent on the BSE in Thursday's intra-day trade after the pharma company posted a net loss of 22.4 crore in Q1FY26.
    Copy LinkShare onShare on Share on Share on
    Hikal Ltd. is trading below all available SMAs
    logo
    Alembic Pharmaceuticals Ltd.
    06 Aug 2025
    US FDA Approval
    906.15
    -1.71%
    Alembic Pharma dips 3% post Q1 results; MOFSL retains Neutral, here's why
    Business Standard
    Alembic Pharma fell around 3.5 per cent to hit an intraday low of 913 on the NSE, after the company reported its June 2025 quarter results
    Copy LinkShare onShare on Share on Share on
    Alembic Pharmaceuticals Ltd. is trading below all available SMAs
    Alembic Pharma Q1 Review: Dolat Capital Maintains 'Add', Revises Target Price Here's Why
    NDTV Profit | 06 Aug 2025 1 more
    Alembic Pharma Q1 net profit rises 14% to 154 crore, revenue up 10%
    Business Standard | 05 Aug 2025
    logo
    Gland Pharma Ltd.
    06 Aug 2025
    1951.60
    -1.07%
    'Buy' Gland Pharma Shares Maintains Motilal Oswal On Strong Q1 Earnings Growth, Valuation Check Target Price
    'Buy' Gland Pharma Shares Maintains Motilal Oswal On Strong Q1 Earnings Growth, Valuation Check Target Price
    NDTV Profit
    Gland Pharma is fortifying its positioning in the complex injectable space through in-house product development as well as partnerships, adds the brokerage.
    Copy LinkShare onShare on Share on Share on
    Gland Pharma Ltd.'s price crossed below 50Day SMA today
    Gland Pharma shares jump 6% post Q1 show; should you buy, sell or hold?
    Business Standard | 06 Aug 2025 5 more
    Gland Pharma Share Price Surges Over 6% As Jefferies Upgrades Ratings, Hikes Target Price Post Q1 Results
    NDTV Profit | 06 Aug 2025
    Gland Pharma Q1 Review: Brokerages DividedJefferies Upgrades Rating To Hold, Citi Maintains Sell
    NDTV Profit | 06 Aug 2025
    Gland Pharma Q1 profit jumps 50% on core growth, Cenexi turnaround
    Business Standard | 05 Aug 2025
    Gland Pharma Q1FY26 net profit up 50% at 215 cr
    Business Line | 05 Aug 2025
    Gland Pharma Q1 Results: Profit Surges 50%, Meets Estimates
    NDTV Profit | 05 Aug 2025
    logo
    Eris Lifesciences Ltd.
    06 Aug 2025
    1592.60
    -2.06%
    'Buy' Eris Lifesciences Shares Maintains PL Capital Post Q1 Results; Revises Target Price
    'Buy' Eris Lifesciences Shares Maintains PL Capital Post Q1 Results; Revises Target Price
    NDTV Profit
    Eris maintains revenue growth guidance of 15-20% for FY26E, adds PL Capital
    Copy LinkShare onShare on Share on Share on
    Eris Lifesciences Ltd. is trading below its 30 day SMA of 1713.8
    Eris Lifesciences to target insulin, semaglutide mkt opportunities in FY26
    Business Standard | 05 Aug 2025
    logo
    Aurobindo Pharma Ltd.
    06 Aug 2025
    1090.90
    -0.56%
    Aurobindo Pharma Q1 Results Review: Motilal Oswal Maintains 'Buy' Check Target Price
    Aurobindo Pharma Q1 Results Review: Motilal Oswal Maintains 'Buy' Check Target Price
    NDTV Profit
    Recent hiccups related to manufacturing plant issues and tariff uncertainties have led to volatility in earnings and, subsequently, the stock price, adds the brokerage.
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. is trading above its 50 day SMA of 1085.3
    logo
    Orchid Pharma Ltd.
    05 Aug 2025
    719.80
    -2.41%
    Tesla Leases 33,000 Sq Ft Commercial Space In Gurugram
    Tesla Leases 33,000 Sq Ft Commercial Space In Gurugram
    NDTV Profit
    The Elon Musk-led company has registered a 9-year lease for the unit in Gurugram's Orchid Business Park.
    Copy LinkShare onShare on Share on Share on
    Orchid Pharma Ltd.'s price crossed below 100Day SMA today
    Tesla leases retail space in Gurgaon for its second showroom in India
    Business Standard | 05 Aug 2025
    logo
    Lupin Ltd.
    05 Aug 2025
    US FDA Approval
    1926.80
    -1.87%
    Lupin Q1 Results: Net Profit Jumps 52% To Rs 1,221 Crore
    Lupin Q1 Results: Net Profit Jumps 52% To Rs 1,221 Crore
    NDTV Profit
    Sales rose to Rs 6,164 crore in the first quarter as against Rs 5,514 crore in the year-ago period, Lupin Ltd said in a statement.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. has an average target of 2326.00 from 8 brokers.
    Lupin Q1 results: Net profit jumps 52% to 1,221 cr on strong sales in US
    Business Standard | 05 Aug 2025
    logo
    Alembic Pharmaceuticals Ltd.
    05 Aug 2025
    US FDA Approval
    906.15
    -1.71%
    Alembic Pharmaceuticals first-quarter profit jumps to 154.27 on strong US, domestic sales
    Business Line
    India's generic drugmakers have been facing margin pressures due to lower prices in the US amid fierce competition
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 198 to 192 in Jun 2025 qtr
    logo
    Aurobindo Pharma Ltd.
    05 Aug 2025
    1090.90
    -0.56%
    Aurobindo Pharma stock falls 2% after Q1 results; check key numbers here
    Business Standard
    Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to 824 crore in Q1FY26, as against 918 crore in the same quarter last year
    Copy LinkShare onShare on Share on Share on
    Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings
    Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue
    Business Standard | 05 Aug 2025 4 more
    Aurobindo Pharma Q1 results: Profit drops 10% to 824 crore on US sales
    Business Standard | 04 Aug 2025
    Aurobindo Pharma's Q1 net down 10.2% at 824 cr
    Business Line | 04 Aug 2025
    Aurobindo Pharma Declares Dividend Of Rs 4 Check Record Date, Details
    NDTV Profit | 04 Aug 2025
    Aurobindo Pharma Q1 Results: Profit Falls 10%, Misses Estimates
    NDTV Profit | 04 Aug 2025
    logo
    Sanofi Consumer Healthcare India Ltd.
    04 Aug 2025
    4920.50
    0.38%
    Sanofi Consumer Healthcare Q2 - driven by exports, product launches
    Business Line
    Quarter and half-year financials are not directly comparable due to the demerger and voluntary recall of certain variants of key brands, the company said
    Copy LinkShare onShare on Share on Share on
    Institutional Investors have decreased holdings from 30.00% to 20.13% in Jun 2025 qtr
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Jinkushal Industries
    • Jain Resource Recycling
    • Gurunanak Agriculture
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd